$RNVA
Rennova Health, Inc. Stock $rnva

$rnva Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041175 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue		$3.500M	$2.800M
YoY Change		25.0%	177.16%
Cost Of Revenue		$1.807M	$1.823M
YoY Change		-0.93%	50.98%
Gross Profit		$1.693M	$976.5K
YoY Change		73.42%	-594.44%
Gross Profit Margin		48.39%	34.88%
Selling, General & Admin		$2.276M	$1.810M
YoY Change		25.74%	-10.36%
% of Gross Profit		134.38%	185.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$56.80K	$117.4K
YoY Change		-51.64%	-13.05%
% of Gross Profit		3.35%	12.03%
Operating Expenses		$2.333M	$1.927M
YoY Change		21.03%	-10.53%
Operating Profit		-$601.0K	-$924.8K
YoY Change		-35.02%	-60.67%
Interest Expense		$36.46K	-$605.3K
YoY Change		-106.02%	-13.62%
% of Operating Profit
Other Income/Expense, Net		-$138.6K	-$415.1K
YoY Change		-66.61%	19.89%
Pretax Income		-$739.6K	-$1.340M
YoY Change		-44.8%	-270.56%
Income Tax		-$184.5K
% Of Pretax Income
Net Earnings		-$500.0K	-$1.342M
YoY Change		-62.73%	-200.8%
Net Earnings / Revenue		-14.29%	-47.91%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	-$126.90
COMMON SHARES
Basic Shares Outstanding	40.55B shares	29.93B shares	9.679B shares
Diluted Shares Outstanding		31.40B shares	10.57B shares

Balance Sheet

Concept	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.9K	$10.96K
YoY Change	1030.47%	-96.69%
Cash & Equivalents	$123.9K	$10.96K
Short-Term Investments
Other Short-Term Assets	$156.3K	$116.9K
YoY Change	33.77%	-23.09%
Inventory	$266.0K	$273.6K
Prepaid Expenses
Receivables	$1.791M	$3.331M
Other Receivables	$3.340M	$2.100M
Total Short-Term Assets	$5.677M	$5.833M
YoY Change	-2.67%	90.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.268M	$4.312M
YoY Change	-1.04%	-45.68%
Goodwill
YoY Change
Intangibles	$259.4K	$259.4K
YoY Change	0.0%
Long-Term Investments	$9.016M	$9.016M
YoY Change	0.0%	0.0%
Other Assets	$224.4K	$227.8K
YoY Change	-1.49%	0.77%
Total Long-Term Assets	$14.17M	$14.46M
YoY Change	-1.99%	-17.11%
TOTAL ASSETS
Total Short-Term Assets	$5.677M	$5.833M
Total Long-Term Assets	$14.17M	$14.46M
Total Assets	$19.85M	$20.29M
YoY Change	-2.18%	-1.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.12M	$12.38M
YoY Change	-2.09%	-11.32%
Accrued Expenses	$19.46M	$19.35M
YoY Change	0.56%	9.46%
Deferred Revenue
YoY Change
Short-Term Debt	$8.222M	$8.222M
YoY Change	0.0%	10239.84%
Long-Term Debt Due	$11.61M	$14.37M
YoY Change	-19.17%	-36.39%
Total Short-Term Liabilities	$47.19M	$49.80M
YoY Change	-5.25%	-13.19%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$225.0K	$400.9K
YoY Change	-43.88%	-37.39%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.19M	$49.80M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$47.41M	$50.20M
YoY Change	-5.56%	-13.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.702B	-$1.704B
YoY Change	-0.14%
Common Stock	$3.705M	$1.509M
YoY Change	145.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$27.60M	-$29.90M
YoY Change
Total Liabilities & Shareholders Equity	$19.85M	$20.29M
YoY Change	-2.18%	-1.03%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$500.0K	-$1.342M
YoY Change	-62.73%	-200.8%
Depreciation, Depletion And Amortization	$56.80K	$117.4K
YoY Change	-51.64%	-13.05%
Cash From Operating Activities	-$244.5K	$43.56K
YoY Change	-661.2%	-102.23%
INVESTING ACTIVITIES
Capital Expenditures	$46.55K	$850.00
YoY Change	5376.47%	-98.94%
Acquisitions
YoY Change
Other Investing Activities	-$131.8K	-$112.4K
YoY Change	17.23%	-28.92%
Cash From Investing Activities	-$178.3K	-$78.45K
YoY Change	127.28%	-197.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-178.9K	-81.03K
YoY Change	120.73%	-104.03%
NET CHANGE
Cash From Operating Activities	-244.5K	43.56K
Cash From Investing Activities	-178.3K	-78.45K
Cash From Financing Activities	-178.9K	-81.03K
Net Change In Cash	-601.6K	-115.9K
YoY Change	419.0%	-187.91%
FREE CASH FLOW
Cash From Operating Activities	-$244.5K	$43.56K
Capital Expenditures	$46.55K	$850.00
Free Cash Flow	-$291.0K	$42.71K
YoY Change	-781.36%	-102.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q2	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022Q3	RNVA	Stock Issued During Period Value Conversion Of Series F Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesFPreferredStockIntoCommonStock		usd
CY2022Q3	RNVA	Stock Issued During Period Value Conversion Of Series N Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesNPreferredStockIntoCommonStock		usd
CY2022Q3	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
	RNVA	Proceeds From Hhs Provider Relief Funds ProceedsFromHhsProviderReliefFunds		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000931059
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q3	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit		usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-334989282	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	RNVA	Finance Lease Payments FinanceLeasePayments		usd
	RNVA	Finance Lease Payments FinanceLeasePayments		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	RNVA	Preferred Stock Converted Into Common Stock PreferredStockConvertedIntoCommonStock		usd
	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock		usd
	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions		usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense		usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense		usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense		usd
CY2023Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2022Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35141
	dei	Entity Registrant Name EntityRegistrantName	RENNOVA HEALTH, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	68-0370244
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 S. Australian Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	855-1626
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40551322257	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123898	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499470	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1790952	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	265957	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	242645	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	156308	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	215365	usd
CY2023Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	5677034	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6363162	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4267538	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4194299	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	224413	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	165530	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	400937	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q3	us-gaap	Assets Assets	19845437	usd
CY2022Q4	us-gaap	Assets Assets	20572762	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12122246	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11514322	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19460163	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1674986	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1348425	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1194451	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q3	us-gaap	Loans Payable LoansPayable	2198000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2995000	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	8222240	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8622240	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175923	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1465325	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	47189131	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49308157	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	225014	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q3	us-gaap	Liabilities Liabilities	47414145	usd
CY2022Q4	us-gaap	Liabilities Liabilities	49667350	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37051322257	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37051322257	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29084322257	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29084322257	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3705132	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2908432	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1670775141	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1671571834	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1702042616	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1703577780	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-27559424	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29094588	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-9284	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27568708	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29094588	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19845437	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20572762	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3538095	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2825937	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14843210	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7576693	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1806517	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1823473	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5493670	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4769789	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2275755	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1809835	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6851183	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5262338	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56796	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	117441	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	250288	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	351481	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	4139068	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	3750749	usd
	us-gaap	Costs And Expenses CostsAndExpenses	12595141	usd
	us-gaap	Costs And Expenses CostsAndExpenses	10383608	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-600973	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-924812	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2248069	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2806915	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	281963	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	129451	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	537077	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	87170	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	60808	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	286719	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-15410	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	420551	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	605312	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1404298	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1705502	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-138588	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-415053	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-380502	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1298923	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-739561	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1339865	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1867567	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4105838	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-184524	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	332476	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-555037	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1339865	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1535091	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4105838	usd
CY2023Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1116	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1696	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-9213	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-7075	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-556153	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1341561	usd
	us-gaap	Profit Loss ProfitLoss	1525878	usd
	us-gaap	Profit Loss ProfitLoss	-4112913	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7924	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9286	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-548229	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1341561	usd
	us-gaap	Net Income Loss NetIncomeLoss	1535164	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4112913	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	330876369	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-548229	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1341561	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1535164	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-334989282	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31401420083	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10569572256	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30369571341	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4130876898	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31401420083	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10569572256	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	503057511874	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4130876898	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29094588	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	805560	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28289028	usd
CY2023Q2	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	2	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	1276471	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27012555	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-556153	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27568708	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27301524	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2022Q1	RNVA	Stock Issued During Period Value Payment Of Cash In Lieu Of Fractional Shares StockIssuedDuringPeriodValuePaymentOfCashInLieuOfFractionalShares	9	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2267566	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28569099	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-503786	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28572885	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28572885	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1341561	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1341561	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29914446	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29914446	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1535091	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4105838	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	250288	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	351481	usd
	RNVA	Noncash Interest Income Expense NoncashInterestIncomeExpense	-36455	usd
	RNVA	Noncash Interest Income Expense NoncashInterestIncomeExpense	-80156	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1215	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	286719	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-15410	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
	RNVA	Other Income Loss From Federal Government Relief Funds OtherIncomeLossFromFederalGovernmentReliefFunds	285572	usd
	RNVA	Other Income Loss From Federal Government Relief Funds OtherIncomeLossFromFederalGovernmentReliefFunds	-267758	usd
	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax	9213	usd
	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax	7075	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1320017	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	774975	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23312	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6869	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-59059	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5031	usd
	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	58883	usd
	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	40000	usd
	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-173319	usd
	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-180888	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	607924	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	808097	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-105560	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2722120	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	326561	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-173319	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-180888	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3093226	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1164882	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	9213	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1714	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3102439	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1166596	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1008751	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	506540	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	323527	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	34794	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1332278	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-541334	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	580000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	900000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1377000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	400000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	948733	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1213495	usd
	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements	-476471	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1500000	usd
	RNVA	Proceeds From Hhs Provider Relief Funds ProceedsFromHhsProviderReliefFunds	284339	usd
	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit	9	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2145733	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	994364	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-375572	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-713566	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	499470	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	724524	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123898	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10958	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zUKVjFFDQ2N3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zENXnkGBIOXg">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include the estimates of fair values of assets acquired and liabilities assumed in business combinations, contractual allowances and bad debt reserves, the recoverability of long-lived assets, the valuation allowance relating to the Company’s deferred tax assets, the valuations of investments, equity and derivative instruments, deemed dividends, litigation and related reserves, among others. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z7b8cua5pkhl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zKQ1opNB6hM8">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	330500000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	330876369	usd
CY2023Q3	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-547113	usd
CY2022Q3	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-1339865	usd
CY2023Q3	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	9500000	usd
CY2022Q3	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	10200000	usd
CY2023Q3	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	2000000.0	usd
CY2022Q3	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	1600000	usd
CY2023Q3	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	11500000	usd
CY2022Q3	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	11800000	usd
CY2023Q3	us-gaap	Revenues Revenues	3500000	usd
CY2022Q3	us-gaap	Revenues Revenues	2800000	usd
	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	29100000	usd
	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	23400000	usd
	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	4300000	usd
	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	5700000	usd
	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	33400000	usd
	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	29100000	usd
	us-gaap	Revenues Revenues	14800000	usd
	us-gaap	Revenues Revenues	7600000	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2023Q3	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	0	usd
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	0	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10,000
CY2022Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	10000	shares
CY2023Q3	RNVA	Working Capital Deficit WorkingCapitalDeficit	41500000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-27600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1500000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-547113	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1339865	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1544377	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4105838	usd
	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	1544377	usd
	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-334982207	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1116	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1696	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-9213	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-7075	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-548229	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1341561	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1535164	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-334989282	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31401420083	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10569572256	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30369571341	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4130876898	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	20977778506	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	451710162027	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31401420083	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10569572256	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	503057511874	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4130876898	shares
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	984861817781	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1006818817784	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	519133405942	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1006818817784	shares
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	10994910	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13046646	usd
CY2023Q3	RNVA	Allowance For Contractual Obligations Current AllowanceForContractualObligationsCurrent	7856255	usd
CY2022Q4	RNVA	Allowance For Contractual Obligations Current AllowanceForContractualObligationsCurrent	8529904	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1347703	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1405773	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1790952	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8525232	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8533710	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	266527	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	552099	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	6720113	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5736096	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	498000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	534550	usd
CY2023Q3	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	861046	usd
CY2022Q4	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	2101837	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2589245	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2105516	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19460163	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7000000.0	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7000000.0	usd
CY2022Q4	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	2100000	usd
	RNVA	Reduction In Overpayment Reserve ReductionInOverpaymentReserve	1200000	usd
CY2023Q3	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	900000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1194451	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q3	us-gaap	Loans Payable LoansPayable	2198000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2995000	usd
CY2023Q3	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8222240	usd
CY2022Q4	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8622240	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	11614691	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	14534630	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	11614691	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14534630	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	1194451	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2917390	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1194451	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	82347	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	83211	usd
	us-gaap	Lease Cost LeaseCost	257262	usd
	us-gaap	Lease Cost LeaseCost	248250	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	36455	usd
	us-gaap	Interest Expense InterestExpense	36455	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	400937	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q3	RNVA	Lease Assets LeaseAssets	400937	usd
CY2022Q4	RNVA	Lease Assets LeaseAssets	574256	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175923	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	225014	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q3	RNVA	Lease Liabilities LeaseLiabilities	621398	usd
CY2022Q4	RNVA	Lease Liabilities LeaseLiabilities	794717	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82347	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	83211	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	257262	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	248250	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	220365	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	218846	usd
CY2023Q3	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2022Q4	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	217839	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	224252	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	223795	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	18650	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	460284	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	224252	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	59347	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3791	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	400937	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	220461	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175923	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	225014	usd
	RNVA	Percentage Of Market Price PercentageOfMarketPrice	0.85	pure
CY2023Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	330500000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.90	pure
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29100000000	shares
	us-gaap	Interest Paid Net InterestPaidNet	419177	usd
	us-gaap	Interest Paid Net InterestPaidNet	1369955	usd
	RNVA	Preferred Stock Converted Into Common Stock PreferredStockConvertedIntoCommonStock	17500	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	496530	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	2352000	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo	220500	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo	638000	usd
	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock	333333	usd
	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions	330543036	usd
	RNVA	Noncash Interest Income NoncashInterestIncome	36455	usd
	RNVA	Noncash Interest Income NoncashInterestIncome	80056	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	350259	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	341046	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1465325	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1696	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	5941	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	1116	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	9213	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	1134	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1116	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1696	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-9213	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-7075	usd

Files In Submission

Name	View Source	Status
0001493152-23-041175-index-headers.html	Edgar Link	pending
0001493152-23-041175-index.html	Edgar Link	pending
0001493152-23-041175.txt	Edgar Link	pending
R5.htm	Edgar Link	pending
0001493152-23-041175-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnva-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
rnva-20230930_def.xml	Edgar Link	unprocessable
rnva-20230930_cal.xml	Edgar Link	unprocessable
rnva-20230930_lab.xml	Edgar Link	unprocessable
rnva-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNVA
Rennova Health, Inc. Stock $rnva

2023 Q4 Form 10-Q Financial Statement

#000149315223041175 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA Rennova Health, Inc. Stock $rnva

2023 Q4 Form 10-Q Financial Statement

#000149315223041175 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA
Rennova Health, Inc. Stock $rnva